All Things Urticaria – Learning about urticaria with Prof. Dr. Torsten Zuberbier

Urticaria Tracking with CRUSE: A Game-Changer for Patients & Research

All Things Urticaria – Learning about urticaria with Prof. Dr. Torsten Zuberbier

Show Notes

In this episode, Prof. Dr. Torsten Zuberbier (GA²LEN) welcomes Dr. Sophia Neisinger to discuss CRUSE, a digital health tool for chronic spontaneous urticaria (CSU). CRUSE is a free, globally available self-evaluation app that helps patients track their symptoms and provides valuable research data to improve urticaria care.

They discuss: 📊 How CRUSE helps patients track their CSU symptoms daily. 🔬 How anonymized CRUSE data is shaping global urticaria research. 📢 The importance of continuous data input—even on good days. 💊 Treatment disparities worldwide & the fight against long-term corticosteroid use. 📡 Upcoming developments, including smartwatch & wearable integration. Join us as we explore how CRUSE is making a difference for patients, physicians, and researchers worldwide!

Key Learnings from the Episode: CRUSE is a free, validated self-evaluation app for CSU patients, helping track their disease and treatment effectiveness. Daily symptom tracking is crucial, even when patients feel well, to improve research insights. CRUSE data reveals treatment disparities worldwide, with some countries lacking access to second-line treatments. Systemic corticosteroids are still overused, despite their severe side effects, highlighting the need for better awareness and alternative treatments. CRUSE allows patients to share their symptom data with their physicians, improving personalized treatment decisions. The app is continuously evolving, with new features like improved reports and future integration with smartwatches and wearables. CRUSE is expanding globally, with North Macedonia being the next country to adopt the platform. Physicians and researchers can use CRUSE for studies, making it a valuable tool for small-scale trials and real-world data collection.

Chapters 00:00 Introduction to CRUISE and Its Purpose 03:18 Data Collection and Patient Engagement 05:47 Global Insights from CRUISE Data 08:52 Future Developments and Enhancements 11:35 Awareness and Advocacy for Urticaria

Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.

Feedback form: ATU: ⁠⁠⁠https://forms.office.com/e/m6a2uEdsUH

More from All Things Urticaria – Learning about urticaria with Prof. Dr. Torsten Zuberbier

Sep 30, 2026

In this episode of the UCARE Global Allergy and Asthma Excellence Network podcast on Urticaria, Prof. Torsten Zuberbier speaks with Prof. Angelo Valerio Marzano from Milan about urticarial vasculitis and its challenging differential diagnoses. They explore how clinicians can distinguish urticarial vasculitis from chronic urticaria and other dermatological or systemic conditions and discuss practical approaches to diagnosis and treatment.

Aug 25, 2026

In this episode of the Global Allergy and Asthma Excellence Network UCARE Podcast on Urticaria, Prof. Torsten Zuberbier speaks with Prof. Marta Ferrer from Spain about an important question: Is chronic spontaneous urticaria (CSU) only a skin disease, or is it a systemic inflammatory condition? Together, they discuss emerging evidence showing that urticaria affects far more than the skin and how this should influence patient management.

Jul 21, 2026

In this episode of the UCARE Global Allergy and Asthma Excellence Network (Global Allergy and Asthma Excellence Network) podcast on Urticaria, Prof. Torsten Zuberbier speaks with Prof. Akio Tanaka from Hiroshima University, Japan, about an important question many patients ask: how long will chronic urticaria last, and can treatment influence the course of the disease? They discuss disease modification, symptom control, and future research directions in urticaria management.

Jun 16, 2026

In this episode of the UCARE GA²LEN (Global Allergy and Asthma Excellence Network) podcast on Urticaria, Prof. Torsten Zuberbier and Prof. Hermenio Lima discuss the growing role of artificial intelligence (AI) in medicine and how it may influence urticaria care, research, and patient management in the future.

May 19, 2026

In this episode of the UCARE GA²LEN (Global Allergy and Asthma Excellence Network) podcast on Urticaria, Prof. Torsten Zuberbier and Prof. Maia Gotua discuss the role of infections in acute and chronic urticaria. They explore how infections can trigger, mimic, or worsen symptoms—and why careful clinical evaluation is key.

See all episodes →